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e examined the temporal and causal relationship
between Smac/DIABLO release, cytochrome 
 
c
 
(cyt-
 
c
 
) release, and caspase activation at the single
cell level during apoptosis. Cells treated with the broad-
spectrum caspase inhibitor z-VAD-fmk, caspase-3 (Casp-3)–
deﬁcient MCF-7 cells, as well as Bax-deﬁcient DU-145
cells released Smac/DIABLO and cyt-
 
c
 
 in response to
proapoptotic agents. Real-time confocal imaging of MCF-7
cells stably expressing Smac/DIABLO-yellow ﬂuorescent
protein (YFP) revealed that the average duration of Smac/
DIABLO-YFP release was greater than that of cyt-
 
c
 
-green
W
 
ﬂuorescent protein (GFP). However, there was no signiﬁ-
cant difference in the time to the onset of release, and both
cyt-
 
c
 
-GFP and Smac/DIABLO-YFP release coincided with
mitochondrial membrane potential depolarization. We also
observed no signiﬁcant differences in the Smac/DIABLO-YFP
release kinetics when z-VAD-fmk–sensitive caspases were
inhibited or Casp-3 was reintroduced. Simultaneous mea-
surement of DEVDase activation and Smac/DIABLO-YFP
release demonstrated that DEVDase activation occurred
within 10 min of release, even in the absence of Casp-3.
 
Introduction
 
During apoptosis, mitochondria increase their membrane
permeability (Martinou and Green, 2001). Several proteins
that normally reside in the intermembrane and intracristal
space are released during this process. The release of cyto-
chrome 
 
c
 
 (cyt-
 
c
 
) triggers the formation of a multiprotein
complex, the apoptosome (Liu et al., 1996). This complex
is composed of apoptotic protease-activating factor 1, pro-
caspase-9, dATP, and cyt-
 
c
 
 (Li et al., 1997; Zou et al.,
1997). Apoptosome formation results in the activation of
executioner caspases including caspase-3 (Casp-3), -6, and -7
(Li et al., 1997; Slee et al., 1999; Zou et al., 1997). The loss of
cyt-
 
c
 
 simultaneously initiates a mitochondrial organelle
dysfunction program that is characterized by inner mito-
chondrial membrane potential (
 
  
 
M
 
) depolarization, ATP
depletion, and free radical production (Zamzami et al.,
1995; Adachi et al., 1997; Cai and Jones, 1998; Heiskanen
et al., 1999; Mootha et al., 2001; Waterhouse et al., 2001;
Madesh et al., 2002; Dussmann et al., 2003a,b).
Inhibitor of apoptosis proteins (IAPs) are believed to be
naturally occurring inhibitors of caspase activation (Holcik
and Korneluk, 2001). During apoptosis, two other proteins
are released from mitochondria that facilitate apoptosome
formation by neutralizing the antiapoptotic activity of IAPs:
the second mitochondria-derived activator of caspase/direct
IAP binding protein with low pI (Smac/DIABLO) and
Omi/HtrA2, the mammalian homologue of the 
 
Escherichia
coli
 
 heat shock–inducible protein HtrA (Du et al., 2000;
Verhagen et al., 2000; Suzuki et al., 2001; Hegde et al.,
2002; Martins et al., 2002; Verhagen et al., 2002). Both
proteins bind IAPs by direct interaction within specific do-
mains designated BIR domains.
Interestingly, the release of both cyt-
 
c
 
 and Smac/DIABLO
has been shown to be a prerequisite for apoptotic cell death in
several model systems, such as nerve growth factor depriva-
tion–induced cell death of sympathetic neurons and antican-
cer drug-induced tumor cell death (Deshmukh et al., 2002;
Fulda et al., 2002; Hunter et al., 2003). However, despite the
importance of Smac/DIABLO release for various cell death
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Figure 1. Comparison of Smac/DIABLO and cyt-c release during apoptosis: effect of Casp-3 and z-VAD-fmk–sensitive caspases. (A) MCF-7/Casp-3 
cells and MCF-7 cells were treated with 3  M STS or 3  M STS plus 200  M of the broad-spectrum caspase inhibitor z-VAD-fmk for the 
indicated time periods. Release of Smac/DIABLO and cyt-c from the mitochondria-containing pellet fractions into the cytosol was analyzed 
by Western blotting. Controls were treated with DMSO. Experiments were repeated twice with similar results. (B) Immunofluorescence analysis 
showing the redistribution of cyt-c and Smac/DIABLO during apoptosis. Cells were treated with 3  M STS, 3  M STS plus 200  M z-VAD-fmk 
or 200 ng/ml, and 1  g/ml TNF- /CHX for 6 h. Control cells received vehicle (DMSO). Arrows indicate cells that show a cyt-c and Smac/DIABLO 
redistribution in response to the agents. Nuclear morphology was detected by Hoechst staining. Bar, 10  m. (C) Quantification of cells showing 
cyt-c or Smac/DIABLO release as judged by immunofluorescence analysis. MCF-7/Casp-3 cells (indicated as Casp-3  ) were treated with 
3  M STS. MCF-7 cells (indicated as Casp-3  ) were treated with 3  M STS in the presence or absence of 200  M z-VAD-fmk. Data were 
collected from n   200–300 cells per treatment in 11–14 randomly selected image frames from n   3 independent experiments. There was 
no statistically significant difference between the three treatment groups or between cyt-c and Smac/DIABLO release at any time point investigated. 
Error bars equal SEM.
 
paradigms, the mechanism of Smac/DIABLO release during
apoptosis is not fully characterized. Indeed, controversial data
exist in the literature as to whether the release of Smac/
DIABLO requires or actually precedes caspase activation (Ad-
rain et al., 2001; Chauhan et al., 2001; Zhang et al., 2001).
Moreover, little is known about the temporal and causal rela-
tionship between Smac/DIABLO release and cyt-
 
c
 
 release,
mitochondrial dysfunction, and effector caspase activation atT
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the single cell level. To address these questions, we used real-
time single cell analyses in combination with well-established
model systems, HeLa cells, and the Casp-3–deficient MCF-7
breast adenocarcinoma cell line (Janicke et al., 1998).
 
Results
 
Release of Smac/DIABLO from mitochondria 
during apoptosis can occur independent of Casp-3 
and z-Val-Ala-Asp(
 
O
 
-methyl)-fluoromethylketone 
(z-VAD-fmk)–sensitive caspases
 
We investigated the process of Smac/DIABLO and cyt-
 
c
 
 re-
lease during apoptosis in Casp-3–deficient MCF-7 cells and
MCF-7 cells stably transfected with Casp-3 (MCF-7/Casp-
3; Janicke et al., 1998). Exposure of MCF-7/Casp-3 cells to
proapoptotic agents such as staurosporine (STS), etoposide
(Eto), or TNF-
 
 
 
 plus cycloheximide (TNF-
 
 
 
/CHX) results
in an efficient activation of effector caspases that is followed
in 
 
 
 
30 min by cell shrinkage, membrane blebbing, chroma-
tin condensation, and DNA fragmentation (Janicke et al.,
1998; Luetjens et al., 2001; Rehm et al., 2002). In contrast,
due to the lack of Casp-3, effector caspase activation sets in
slower and less efficient in MCF-7 cells and is largely medi-
ated by caspase-7 (Cuvillier et al., 2001; Liang et al., 2001;
Rehm et al., 2002). Cell shrinkage is delayed by 
 
 
 
120 min,
and cell death sets in without oligonucleosomal DNA frag-
mentation (Janicke et al., 1998; Rehm et al., 2002). We ac-
tivated the mitochondrial apoptosis pathway in both cell
types by addition of 3 
 
 
 
M of the protein kinase inhibitor
STS. Selective plasma membrane permeabilization and sub-
sequent immunoblotting revealed that cyt-
 
c
 
 and Smac/
DIABLO were both released from mitochondria and accu-
mulated in the cytosol after 4 h of STS treatment, indepen-
dent of the presence or absence of Casp-3 (Fig. 1 A). Similar
results were obtained in MCF-7 and MCF-7/Casp-3 cells af-
ter treatment with submaximal STS concentrations (0.1 
 
 
 
M)
or after stimulation of death receptors with TNF-
 
 
 
/CHX
(unpublished data).
A previous report has demonstrated that the broad-spec-
trum caspase inhibitor z-VAD-fmk inhibited the accumula-
tion of Smac/DIABLO in the cytosol during apoptosis (Ad-
rain et al., 2001). MCF-7 cells treated with STS and 200
 
 
 
M z-VAD-fmk indeed showed a significantly reduced ac-
cumulation of Smac/DIABLO in the cytosol, particularly at
later time points. This effect was also detectable in the case
of cyt-
 
c
 
. However, neither Smac/DIABLO nor cyt-
 
c
 
 release
was significantly influenced by the caspase inhibitor as
judged by a decrease in Smac/DIABLO and cyt-
 
c
 
 in the mi-
tochondria-containing pellet fraction comparable to that
seen after STS-only treatment (Fig. 1 A).
These results were confirmed by immunofluorescence anal-
ysis of Smac/DIABLO and cyt-
 
c
 
 distribution during apopto-
sis. MCF-7 and MCF-7/Casp-3 cells were treated with 3 
 
 
 
M
STS for 6 h, either in the absence or presence of 200 
 
 
 
M
z-VAD-fmk. Cells were fixed, immunostained for Smac/
DIABLO and cyt-
 
c
 
, and analyzed by fluorescence microscopy.
Fig. 1 B demonstrates changes in the Smac/DIABLO and cyt-
 
c
 
signals in response to STS in MCF-7 and MCF-7/Casp-3
cells. We noted a concomitant decrease in the mitochondrial
Smac/DIABLO and cyt-
 
c
 
 immunofluorescence signals in in-
dividual MCF-7 and MCF-7/Casp-3 cells during the STS
treatment (Fig. 1 B), suggesting that the two proteins were
coreleased during apoptosis. Similar results were obtained in
STS plus z-VAD-fmk–treated MCF-7 cells (Fig. 1 B). The
Figure 2. Effect of caspase and proteasome inhibition on the 
release of mitochondrial proteins. (A) Western blot analysis of 
Casp-3–deficient MCF-7 cells treated with 3  M STS for 8 h in com-
bination with 200  M z-VAD-fmk and/or 1  M of the proteasome 
inhibitor lactacystin. Release of Smac/DIABLO and cyt-c from mito-
chondria containing pellet fraction into the cytosol was analyzed by 
Western blotting. Controls were treated with DMSO.  -Tubulin and 
porin served as control for equal loading of the samples. Experiment 
was repeated twice with similar results. (B) Western blot analysis of 
the cytosol and mitochondria-containing pellet fraction of HeLa 
D98 cells exposed to 3  M STS for 8 h, either in the absence or 
presence of z-VAD-fmk or lactacystin. Experiment was repeated 
with similar results. (C) Western blot analysis demonstrating the 
processing of caspase-2, -9, and -7 in Casp-3–deficient MCF-7 cells 
treated with 3  M STS for 8 h and its inhibition by 200  M 
z-VAD-fmk.  -Tubulin served as control for equal sample loading.T
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Characterization of MCF-7 cells expressing 
a Smac/DIABLO-YFP
 
To monitor the release of Smac/DIABLO in real-time, we
generated MCF-7 and MCF-7/Casp-3 cells expressing a fu-
sion protein comprised of Smac/DIABLO and YFP. Import
of Smac/DIABLO-YFP into mitochondria was confirmed
by confocal analysis of Smac/DIABLO-YFP fluorescence
and its colocalization with the 
 
  
 
M
 
-sensitive dye tetra-
methyl rhodamine methyl ester (TMRM; Fig. 4 A). We sub-
sequently examined the release behavior of the fusion pro-
tein during apoptotic cell death compared with endogenous
Smac/DIABLO and cyt-
 
c
 
. Immunoblotting experiments
were performed with subcellular fractions of transfected
MCF-7 cells exposed to 3 
 
 
 
M STS for increasing time peri-
ods (Fig. 4 B). The redistribution of Smac/DIABLO-YFP
from the mitochondria to the cytosol during apoptosis was
similar to that of endogenous Smac/DIABLO and cyt-
 
c
 
.
Comparable results were obtained in Smac/DIABLO-YFP–
expressing MCF-7/Casp-3 cells (unpublished data). Cells
that released the Smac/DIABLO-YFP fusion protein in re-
sponse to STS or TNF-
 
 
 
/CHX also showed a redistribution
of Smac/DIABLO immunofluorescence (Fig. 4 C). Similar
results were obtained when we analyzed Smac/DIABLO-
YFP fluorescence and cyt-
 
c
 
 immunofluorescence redistribu-
tion during apoptosis (Fig. 4 D). Hence, this system enabled
one to reliably monitor Smac/DIABLO release at the single
cell level during apoptosis.
 
Real-time single cell analysis of Smac/DIABLO-YFP 
and cyt-
 
c
 
-GFP release demonstrates differences 
in the kinetics, but not in the onset of release
 
We monitored individual MCF-7 cells expressing either
Smac/DIABLO-YFP or a cyt-
 
c
 
-GFP fusion protein (Luet-
jens et al., 2001; Dussmann et al., 2003a,b) by time lapse
confocal microscopy during STS-induced apoptosis. As re-
ported previously, individual cells released cyt-
 
c
 
-GFP at dif-
ferent time points after addition of the proapoptotic agent,
and the majority of the cyt-
 
c
 
-GFP fusion protein was re-
leased in one step that was completed within 10 min (Fig. 5,
A and B; Goldstein et al., 2000; Luetjens et al., 2001). The
enhanced degradation of Smac/DIABLO in STS plus z-VAD-
fmk–treated cells observed in the permeabilization/immuno-
blotting experiments was also reflected by a decreased immu-
nofluorescence brightness in cells that had released Smac/
DIABLO. Concomitant redistribution of Smac/DIABLO and
cyt-
 
c
 
 could also be detected in response to TNF-
 
 
 
/CHX (Fig.
1 B). Cells that had released only one of the two intermem-
brane proteins could not be specifically identified in these ex-
periments. However, in cells that released both proteins, the
cyt-
 
c
 
 immunofluorescence signal appeared frequently more
diffuse than the Smac/DIABLO signal. A quantitative immu-
nofluorescence analysis of Smac/DIABLO and cyt-
 
c
 
 release in
MCF-7/Casp-3, MCF-7, and z-VAD-fmk treated MCF-7
cells demonstrated that the level of caspase activation did not
influence the occurrence of cyt-
 
c
 
 or Smac/DIABLO release in
response to STS (Fig. 1 C).
 
Caspase inhibition accelerates a lactacystin-sensitive 
degradation of Smac/DIABLO
 
It has been reported previously that Smac/DIABLO is sub-
ject to proteasomal degradation (MacFarlane et al., 2002;
Hu and Yang, 2003). To investigate whether z-VAD-fmk
may promote the degradation of Smac/DIABLO after its
release, we treated MCF-7 cells for 8 h with 3 
 
 
 
M STS in
the presence or absence of 200 
 
 
 
M z-VAD-fmk or 1 
 
 
 
M
of the proteasome inhibitor lactacystin (Fig. 2 A). STS-
only treatment induced the cytosolic accumulation of
Smac/DIABLO and cyt-
 
c
 
, whereas STS plus z-VAD-fmk–
treated cultures showed a reduced accumulation of both
proteins in the cytosolic fraction, despite complete release
from mitochondria. When cells were treated with lactacys-
tin, high amounts of Smac/DIABLO and cyt-
 
c
 
 reappeared
in the cytosolic fraction of STS plus z-VAD-fmk treated
cells. A higher cytosolic content of Smac/DIABLO was
also observed in STS plus lactacystin- versus STS-only–
treated cultures, suggesting that Smac/DIABLO is also
partially degraded when caspase activation is not blocked.
Similar effects were observed in HeLa D98 cells (Fig. 2 B).
z-VAD-fmk–insensitive release of Smac/DIABLO was also
observed in MCF-7 cells treated with the topoisomerase II
inhibitor Eto (unpublished data).
To investigate which caspases were sensitive to z-VAD-
fmk in our experimental setting, we performed an immuno-
blot analysis of STS- and STS plus z-VAD-fmk–treated
MCF-7 cells. Treatment with z-VAD-fmk potently inhib-
ited the processing of initiator caspases 9 and 2, and blocked
the formation of the p18 and p20 active subunits of caspases
9 and 7, respectively (Fig. 2 C).
 
Release of Smac/DIABLO during apoptosis can occur 
independent of Bax
 
To investigate whether Bax expression is necessary for the re-
lease of Smac/DIABLO from mitochondria, Bax-deficient
human DU-145 prostate cancer cells (Honda et al., 2001)
were treated with 3 
 
 
 
M STS. The cytosolic accumulation of
Smac/DIABLO and cyt-
 
c
 
 detected after digitonization and
immunoblotting. Interestingly, both Smac/DIABLO and
cyt-
 
c
 
 were released from Bax-deficient mitochondria in a
similar time course (Fig. 3).
Figure 3. Release of Smac/DIABLO during apoptosis can occur 
independent of Bax. Bax-deficient DU145 cells were treated with 3 
 M STS for the indicated time periods. Release of Smac/DIABLO 
and cyt-c from the mitochondria-containing pellet fractions into 
the cytosol was analyzed by Western blotting. Controls were treated 
with DMSO. Experiments were repeated twice with similar results.T
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cyt-c-GFP redistribution was indicated by a decrease in
the standard deviation of the average pixel. Confocal imag-
ing of Smac/DIABLO-YFP redistribution revealed a compa-
rable type of release. The majority of the fluorescence signal
was redistributed in a single step, albeit the duration of the
Smac/DIABLO-YFP release was significantly increased (Fig.
5, A and C). We simultaneously monitored changes in the
mitochondrial uptake of the voltage-sensitive probe TMRM
in order to determine the temporal relationship between
Smac/DIABLO-YFP, cyt-c-GFP release, and mitochondrial
Figure 4. Characterization of MCF-7 cells 
expressing Smac/DIABLO-YFP. (A) Confocal 
microscopy showing the colocalization of Smac/
DIABLO-YFP (green) and TMRM (red) in mito-
chondria of untreated cells. The overlay image 
shows yellow pixels at the sites of colocalization. 
Extended view calculated from three confocal 
sections with 0.1  M steps in vertical direction 
with 0.67  m resolution and 0.23  m resolution 
in horizontal direction. Bar, 10  m. (B) Western 
blot analysis of MCF-7 cells stably expressing 
Smac/DIABLO-YFP. Cells were treated with 3  M 
STS for the indicated time periods. Release of 
Smac/DIABLO, Smac/DIABLO-YFP, and cyt-c 
from the mitochondria-containing pellet fractions 
into the cytosol was analyzed by Western blotting. 
Control received DMSO for 8 h. Experiment was 
repeated twice with similar results. (C) Smac/
DIABLO-YFP fluorescence and Smac/DIABLO 
immunofluorescence of MCF-7 cells treated for 6 h 
with 3  M STS or 200 ng/ml and 1  g/ml TNF- /
CHX. Arrows indicate cells that show a Smac/
DIABLO-YFP or Smac/DIABLO redistribution. 
Control cells received DMSO. Nuclear morphol-
ogy was detected by Hoechst staining. Bar, 10  m. 
(D) Smac/DIABLO-YFP fluorescence and cyt-c 
immunofluorescence of MCF-7 cells treated for 6 h 
with 3  M STS or 3  M STS plus 200  M z-VAD-
fmk. Control cells received vehicle (DMSO). 
Nuclear morphology was detected by Hoechst 
staining. Arrows indicate cells that show a Smac/
DIABLO-YFP or cyt-c redistribution. Bar, 10  m.T
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Figure 5. Comparison of the kinetics and onset of cyt-c-GFP and Smac/DIABLO-YFP release in MCF-7 cells. (A) Confocal image series of 
two typical cells transfected with cyt-c-GFP or Smac/DIABLO-YFP. Both cells show a redistribution of the fluorescence signal in response to 
3  M STS. The onset of release was set to time point zero. The individual traces of the standard deviation of the pixel intensities for the two T
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dysfunction during apoptosis. In both cases, release of cyt-
c-GFP and Smac/DIABLO-YFP coincided with   M depo-
larization indicated by a decrease in mitochondrial TMRM
uptake (Fig. 5, B and C). This suggested that cyt-c-GFP and
Smac/DIABLO-YFP are released at a similar time point dur-
ing STS-induced apoptosis.
A quantitative analysis of the onset of cyt-c-GFP and
Smac/DIABLO-YFP release in response to STS confirmed
our observation that there was no significant difference in
the onset of release (Fig. 5 D). However, the average dura-
tion of the Smac/DIABLO-YFP release, calculated as half-
life time, was significantly prolonged 3.4-fold when compared
with cyt-c-GFP (Fig. 5 D). Similar Smac/DIABLO-YFP re-
lease kinetics were observed when apoptosis was triggered by
an activation of death receptors (Fig. 5 E).
A Smac/DIABLO-DsRed tetramer is not released 
from mitochondria
The difference in release kinetics of cyt-c-GFP and Smac/
DIABLO-YFP could be size dependent. To test this hypoth-
esis further, we generated a Smac/DIABLO-DsRed fusion
protein that was readily imported into mitochondria of
MCF-7 cells judged by the colocalization with cyt-c-GFP
(Fig. 6, A–C and G–I). As DsRed is only fluorescent as a tet-
ramer (Baird et al., 2000), the size of the red emitting Smac/
DIABLO–DsRed complex is  188 kD. Time-lapse confo-
cal imaging experiments of MCF-7 cells cotransfected with
Smac/DIABLO-DsRed and cyt-c-GFP revealed that treat-
ment with 3  M STS triggered the release of cyt-c-GFP,
whereas Smac/DIABLO-DsRed retained in mitochondria
(Fig. 6, D–F and J–L). Absence of Smac/DIABLO-DsRed
release was observed in 16 out of 16 cyt-c-GFP release-posi-
tive cells in three separate time-lapse experiments.
Casp-3 and z-VAD-fmk–sensitive caspases 
are not required for a rapid and complete release 
of Smac/DIABLO-YFP during STS-induced apoptosis
Our digitonization/immunoblotting and immunofluores-
cence experiments suggested that the release of Smac/
DIABLO from mitochondria during STS-induced apopto-
sis was not influenced by Casp-3 or z-VAD-fmk–sensitive
caspases. However, the possibility remained that significant
differences existed at the single cell level, which could not
be resolved using the above techniques. Therefore, we ana-
lyzed the kinetics of Smac/DIABLO-YFP release in re-
sponse to STS by time-lapse confocal microscopy in MCF-
7/Casp-3 cells, MCF-7 cells, and z-VAD-fmk–treated
MCF-7 cells. In parallel, we monitored changes in mito-
cells are shown below. For direct comparison of the release kinetics, traces were scaled from 100 (baseline before release) to 0 (baseline after 
completion of the release). Bar, 5  m. (B and C) Individual traces of Smac/DIABLO-YFP– or cyt-c-GFP–expressing MCF-7 cells treated with 
3  M STS. The release of Smac/DIABLO-YFP and cyt-c-GFP was detected as a reduction in the standard deviation of the YFP or GFP pixel 
intensity, respectively. Changes in mitochondrial TMRM uptake were calculated by determining the average pixel intensity in the TMRM-sensitive 
channel. Diamonds and squares indicate corresponding TMRM- and YFP-fluorescence changes of two individual cells. (D) Scatter plot showing 
the onset of cyt-c-GFP (black diamonds) or Smac/DIABLO-YFP (open squares) release in individual cells and their corresponding half-life 
time of the standard deviation decrease, a measure of the release duration (see Materials and methods). Cells were transfected with either 
cyt-c-GFP or Smac/DIABLO-YFP, treated with 3  M STS and observed by confocal microscopy. Mean values are represented by a gray 
diamond or square, respectively ( SD in both dimensions). The duration of the Smac/DIABLO-YFP release was greater than that of cyt-c-GFP 
(t test; P   0.05), whereas no significant difference was observed regarding the time point of release onset (t test). Data were collected from 
n   18 and 25 cells in three and five experiments, respectively. Asterisk indicates significance (t test); P   0.05; n.s., not significant. (E) Kinetics of 
Smac/DIABLO-YFP release in MCF-7 cells in response to TNF- /CHX. Individual trace of a typical cell is shown. Similar traces were obtained 
from n   8 cells in three separate experiments.
Figure 6. Smac/DIABLO-DsRed is not 
released from mitochondria. MCF-7 
cells cotransfected with cyt-c-GFP and 
Smac/DIABLO-DsRed before (A–C) and 
40 min after (D–F) an exposure to 3  M 
STS. The cell indicated by arrows re-
leased cyt-c-GFP, but retained its mito-
chondrial Smac/DIABLO-DsRed signal. 
Similar results were obtained in 16 cells 
from three separate time-lapse experi-
ments. Bar, 10  m. High resolution im-
age of an MCF-7 control cell (G–I) and 
an MCF-7 cell treated for 6 h with 3  M 
STS (J–L). Note the redistribution of 
cyt-c-GFP into the cytosol and nucleus 
after STS treatment, whereas Smac/
DIABLO-DsRed fluorescence retained 
in mitochondria. Bar, 10  m.T
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chondrial TMRM uptake, indicative of   M depolariza-
tion. Confocal imaging of Smac/DIABLO-YFP fluores-
cence redistribution revealed that the majority of Smac/
DIABLO-YFP was released in one single step, regardless of
the level of caspase activation (Fig. 7 A). Moreover, the re-
lease was always associated with a decrease in mitochondrial
TMRM uptake. To calculate the average kinetics of Smac/
DIABLO-YFP release, cells were synchronized to the time
Figure 7. Casp-3 and z-VAD-fmk–sensitive caspases do not accelerate the kinetics of Smac/DIABLO-YFP release in response to STS. 
(A) Quantification of Smac/DIABLO-YFP release and mitochondrial TMRM uptake in cells expressing Smac/DIABLO-YFP. MCF-7/Casp-3 
cells, Casp-3–deficient MCF-7 cells and 200  M z-VAD-fmk–treated MCF-7 cells were equilibrated with 30 nM TMRM and treated with 3 
 M STS. Mean traces were calculated from single cell kinetics synchronized to the time of Smac/DIABLO-YFP release. For direct comparison 
of the release kinetics, traces were scaled from 100 (baseline before release) to 0 (baseline after completion of the release). Bars,  SEM. 
(B) Comparison of Smac/DIABLO-YFP release kinetics. Single cell release kinetics were fitted with an exponential decay function and the 
corresponding half-life times were calculated. Asterisk indicates significance (ANOVA and Tukey test). Error bars,  SEM. (C) Comparison of 
the mean standard deviation baseline value reached after completion of the Smac/DIABLO-YFP redistribution. Data in A–C were collected 
from 9 to 18 cells in three to seven independent experiments per treatment. n.s. , not significant. (D and E) Release of Smac/DIABLO-YFP in 
HeLa D98 cells. Cells were treated with 3  M STS in the absence (D) or presence (E) of 200  M z-VAD-fmk. Individual traces of typical cells 
are shown. Similar traces were obtained from n   29 and 15 cells in two separate experiments per treatment.T
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of Smac/DIABLO-YFP release (Fig. 7 A). Analysis of the
half-life time of the release indicated no significant differ-
ences besides a modest difference between MCF-7/Casp-3
cells and z-VAD-fmk–treated MCF-7 cells, with faster re-
lease kinetics in the z-VAD-fmk–treated MCF-7 cells (Fig.
7 B). This difference was not detected in z-VAD-fmk plus
lactacystin cotreated cells (Fig. 7 B). Analysis of the final
standard deviation after the Smac/DIABLO-YFP-release
indicated no significant differences in the extent of Smac/
DIABLO-YFP redistribution, suggesting no differences in
the magnitude of release (Fig. 7 C). As shown previously
in MCF-7/Casp-3 cells,   M depolarized during STS-
induced apoptosis until a new steady-state level was reached
(  M
 cyt-c; Dussmann et al., 2003b). z-VAD-fmk–treated
MCF-7 cells showed an increased TMRM uptake when
  M
 cyt-c was reached, an effect largely attributable to cas-
pase-dependent plasma membrane potential depolarization
(Dussmann et al., 2003b).
We also observed comparable Smac/DIABLO-YFP release
kinetics in STS- and STS plus z-VAD-fmk–treated HeLa
D98 cells (Fig. 7, D and E), confirming our observations in
a second system.
Single cell fluorescence resonance energy transfer 
(FRET) analysis demonstrates that Smac/DIABLO-YFP 
release precedes the activation of DEVDases
Release of cyt-c triggers the formation of the caspase-activat-
ing apoptosome, a process which in many cell types may be
sensitive to IAPs (Holcik and Korneluk, 2001). From a
mechanistic point of view, release of Smac/DIABLO during
apoptosis could, therefore, represent the rate-limiting step in
apoptosome formation. However, it is currently unknown
how much time is required for apoptosome formation and
subsequent DEVDase activation after the release of Smac/
DIABLO. To address this question, we used time-lapse
imaging experiments in MCF-7/Casp-3 and MCF-7 cells
cotransfected with plasmids coding for Smac/DIABLO-YFP
and a recombinant FRET probe. The probe was comprised
of CFP, a linker peptide containing the optimal effector cas-
pase-cleavage site (DEVD), and YFP. The DEVD linker
peptide of the FRET-fusion protein is cleaved upon activa-
tion of DEVDases, resulting in a loss of resonance energy
transfer and an increase in the CFP/YFP emission ratio
(Tyas et al., 2000; Rehm et al., 2002). We have shown pre-
viously that the cleavage of the probe during apoptosis corre-
lated well with the cleavage of endogenous cytosolic or nu-
clear caspase substrates and the activation of executioner
Casp-3 and caspase-7 (Rehm et al., 2002). Fig. 8 A demon-
strates CFP/YFP ratio changes and changes in the YFP redis-
tribution in a MCF-7/Casp-3 cell in response to 3  M STS.
The cell initially showed a stable baseline CFP/YFP emission
ratio, followed by a rapid cleavage of the FRET probe in
 10 min. Of note, the majority of Smac/DIABLO-YFP was
released before the onset of the FRET probe cleavage. As re-
ported previously, Casp-3–deficient MCF-7 cells demon-
strated significantly slower FRET probe cleavage in response
to STS, indicating decreased DEVDase activity (Rehm et
al., 2002; Fig. 8 B). Interestingly, in these cells, the entire
Smac/DIABLO-YFP release was completed before DEVD-
ase activity could be detected. A quantitative analysis of
the time span between release of Smac/DIABLO-YFP and
onset of DEVDase activity showed that MCF-7/Casp-3 cells
required 5.8   1.5 min for the activation of DEVDases.
MCF-7 cells required a significantly longer time period, but
surprisingly also achieved efficient DEVDase activity within
10 min (mean value, 9.5   0.8 min; Fig. 8 C).
Discussion
This is the first comprehensive report, which demonstrates,
in a defined cellular system, the temporal relationship be-
tween mitochondrial cyt-c and Smac/DIABLO release,
Figure 8. Smac/DIABLO-YFP release precedes DEVDase activation. 
(A and B) Individual traces of a MCF-7/Casp-3 cell and a Casp-3–
deficient MCF-7 cell treated with 3  M STS. The release of Smac/
DIABLO-YFP was detected as a reduction in the standard deviation 
of the YFP pixel intensity. DEVDase activation was measured by 
proteolytical FRET-disruption of a CFP-DEVD-YFP fusion protein,
indicated by an increase in the CFP/YFP emission ratio (see Materials 
and methods). (C) Statistical analysis of the lag-time between the on-
set of Smac/DIABLO-YFP release and DEVDase activation (Materials 
and methods). Data were collected from 9 and 10 cells in four and 
five individual experiments per treatment, respectively. DEVDase 
activation was significantly delayed in MCF-7 cells (t test, P   0.05). 
Error bars,  SEM. Asterisk indicates significance (t test); P   0.05. T
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  M depolarization, and effector caspase activation at the
single cell level during apoptosis. We demonstrate that the
release of large quantities of cyt-c and Smac/DIABLO co-
incides with   M depolarization, suggesting that the cause
for these three processes is a single event: a significant and
fast increase in the outer mitochondrial membrane per-
meability. Moreover, using the well-established MCF-7
model system, as well as HeLa D98 cells, we demonstrate
that neither of these events absolutely requires Casp-3 or
z-VAD-fmk–sensitive caspases. Finally, we demonstrate for
the first time in living cells that activation of DEVDases
occurs within 10 min of mitochondrial membrane perme-
abilization.
Using standard techniques such as digitonization/immu-
noblotting and immunofluorescence analysis of Smac/
DIABLO and cyt-c redistribution, we failed to detect sig-
nificant differences in the release behavior of the two in-
termembrane proteins. However, when we used single cell
analysis of cyt-c-GFP and Smac/DIABLO-YFP release, we
noted that Smac/DIABLO-YFP required on average 3.4-
fold more time for the release. An earlier study performed in
HeLa cells expressing a Smac/DIABLO-GFP fusion protein
demonstrated slow release kinetics in response to STS, al-
though a direct comparison with cyt-c-GFP release was not
performed by the authors (Springs et al., 2002). The differ-
ences in the release kinetics between cyt-c-GFP and Smac/
DIABLO-YFP can be attributable to the difference in size of
the proteins. In vitro experiments using reconstituted vesi-
cles have suggested that the release channel of the outer mi-
tochondrial membrane may be very large ( 2 MD) and
may not discriminate between proteins of different sizes
(Kuwana et al., 2002). Our paper suggests that the release
may well be size dependent, and that the cut-off of the
Smac/DIABLO release channel in vivo may be smaller than
 190 kD. However, we cannot exclude the possibility that
different physicochemical properties, such as association
with mitochondrial membranes (Du et al., 2000), also play
an important role in the different release kinetics.
Of note, our paper demonstrates that the onset of release
was not significantly different between Smac/DIABLO-YFP
and cyt-c-GFP. These observations are supported by recent
bulk analyses of permeabilized, tBid-treated HepG2 cells
(Madesh et al., 2002), as well as by the Bcl-2 sensitivity of
both cyt-c and Smac/DIABLO release (Kluck et al., 1997;
Yang et al., 1997; Adrain et al., 2001). Hence, Smac/
DIABLO and cyt-c may show different release and redistri-
bution/degradation kinetics (see Discussion below), yet the
cause for the release of both factors is likely to be a rapid,
Bcl-2–sensitive increase in the outer mitochondrial mem-
brane permeability.
Using HeLa cells and a well-established model system, the
Casp-3–deficient MCF-7 cell line, we demonstrate that
Casp-3 and z-VAD-fmk–sensitive caspases were not required
for the release of Smac/DIABLO from mitochondria during
STS- and Eto-induced apoptosis. Moreover, Casp-3 or
z-VAD-fmk–sensitive caspases did not increase the kinetics of
Smac/DIABLO-YFP release. Therefore, the release of Smac/
DIABLO differs with respect to its caspase dependence from
that of apoptosis-inducing factor, which is bound to the mi-
tochondrial inner membrane and may require additional
processing for an efficient release and activation during
apoptosis (Arnoult et al., 2002; Wang et al., 2002). How-
ever, our data suggest that Casp-3 and/or the activity of
z-VAD-fmk–sensitive caspases was required to stabilize
Smac/DIABLO after its release (Fig. 1 A). This may explain
the apparent discrepancy between our paper and the results
of Martin and coworkers (Adrain et al., 2001) who investi-
gated cytosolic, but not mitochondrial fractions of daunoru-
bicin-, actinomycin D–, and UV irradiation–treated Jurkat
cells in the presence and absence of z-VAD-fmk. In our pa-
per, the proteasome inhibitor lactacystin recovered the cyto-
solic content of Smac/DIABLO in z-VAD-fmk–treated cells,
suggesting that proteasomal activity is responsible for the
rapid degradation of released Smac/DIABLO when caspases
are inhibited. Interestingly, the proteasome inhibitor likewise
increased the cytosolic content of cyt-c in STS- plus z-VAD-
fmk–treated cells. Two reports have demonstrated that in
vitro Smac/DIABLO is subject to proteasomal degradation,
and that IAPs function as ubiquitin-protein ligases (E3) in
this context (MacFarlane et al., 2002; Hu and Yang, 2003).
It is possible that z-VAD-fmk–bound caspases may liberate
large amounts of IAPs, which are then able to trigger the
degradation of Smac/DIABLO and presumably other proap-
optotic factors. However, because cyt-c has not been re-
ported to bind to IAPs, our paper suggests that caspases may
also generally decrease the ability of cells to degrade or release
proteins in a lactacystin-sensitive manner.
Of note, significant amounts of both cyt-c-GFP and Smac/
DIABLO-YFP were redistributed within a few minutes dur-
ing apoptosis. In cells that express IAPs or other inhibitors of
apoptosome formation, the rate-limiting step in caspase acti-
vation may indeed be the release of Smac/DIABLO (Desh-
mukh et al., 2002; Fulda et al., 2002; Hunter et al., 2003).
Our simultaneous analysis of Smac/DIABLO-YFP release
and DEVDase activation not only demonstrated that DEVD-
ases activation occurred downstream of the release but also
described for the first time the temporal relationship between
these two central events during apoptosis. Surprisingly, on
average only 5 min were required to actually trigger execu-
tioner caspase activity in MCF-7/Casp-3 cells. Significantly
more time was required in Casp-3–deficient MCF-7 cells.
Still, significant DEVDase activity was already detectable
within 10 min of release. Therefore, our data demonstrate an
astonishing efficiency of the apoptotic cascade once mito-
chondria have increased their outer mitochondrial mem-
brane permeability and have established conditions that al-
low the formation of caspase-activating complexes.
Materials and methods
Materials
Recombinant human TNF- , CHX, Eto, and embryo-tested mineral oil
were purchased from Sigma-Aldrich. STS was from Alexis. The broad-
spectrum caspase inhibitor z-VAD-fmk was purchased from Bachem;
TMRM was purchased from MobiTec; and lactacystin was purchased from
BIOMOL Research Laboratories, Inc.
pSmac/DIABLO-YFP and pSmac/DIABLO-dsRed
plasmid preparation
The sequence of Smac/DIABLO was amplified from plasmid pEF mouse
DIABLO (Verhagen et al., 2000) by PCR using Pfu polymerase. The prod-
uct was cloned into BglII and KpnI sites of the pEYFP-N1 plasmid or
pdsRed-N1 plasmid (CLONTECH Laboratories, Inc.) and subsequently se-T
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quenced. Oligonucleotide primers were designed to remove the stop
codon of the Smac/DIABLO gene.
Cell culture and transfection
Human breast adenocarcinoma MCF-7 cells, MCF-7/Casp-3 cells stably
transfected with human Casp-3 (Janicke et al., 1998), HeLa D98 cells, and
DU145 cells were cultured in RPMI 1640 medium and DME, respectively,
(Invitrogen) supplemented with 100 U/ml penicillin, 100  g/ml streptomy-
cin, and 10% FCS (PAA). Cells were transfected with 0.6  g of plasmid
DNA (pSmac/DIABLO-YFP, pSmac/DIABLO-DsRed, pGFP-N1-cyt-c [Heis-
kanen et al., 1999], pmyc-CFP-DEVD-YFP [Tyas et al., 2000], and 6  l Li-
pofectamin reagent [Invitrogen]) per milliliter serum-free culture medium
at 37 C for 4 h. For the generation of stable cell lines, transfected cells
were selected in the presence of 1 mg/ml G418 for 2 wk and fluorescent
clones were enriched. Expression of recombinant proteins was verified by
Western blotting. Generation and characterization of MCF-7 cells stably
expressing a cyt-c-GFP fusion protein have been described previously
(Luetjens et al., 2001; Dussmann et al., 2003a). We have shown previously
that cyt-c-GFP is imported into mitochondria and coreleased with endoge-
nous cyt-c after selective outer mitochondrial membrane permeabilization
(Luetjens et al., 2001).
Digitonin permeabilization
The release of mitochondrial proteins into the cytosolic compartment was
analyzed by selective plasma membrane permeabilization (Luetjens et al.,
2001). Extracts were analyzed by Western blot analysis. Control experi-
ments were performed by incubation of untreated cells with permeabiliza-
tion buffer for 45 min and revealed no release of cyt-c and Smac/DIABLO.
Western blotting
Preparation of cell lysates, Western blotting, and immunodetection was
performed as described previously (Rehm et al., 2002). Membranes were
incubated with a rabbit polyclonal antiactive caspase-9 antibody (MF445,
1:1,000; provided by D.W. Nicholson, Merck Frosst, Point Claire-Dorval,
Quebec, Canada), a rabbit polyclonal antiactive p20 caspase-7 antibody
(1:1,000; New England Biolabs, Inc.), a mouse monoclonal antiactive cas-
pase-2 antibody (1:1,000; BD Biosciences), a mouse monoclonal antiporin
antibody (1:1,000; Calbiochem), a mouse monoclonal anti– -tubulin anti-
body (clone DM 1A; 1:5,000; Sigma-Aldrich), a rabbit polyclonal anti–
human Smac/DIABLO antibody (1:5,000; R&D Systems), or a mouse
monoclonal anti–cyt-c antibody (clone 7H8.2C12, 1:1,000; Becton Dick-
inson). The anti-Smac/DIABLO antibody detected both human and mouse
Smac/DIABLO as confirmed with purified mouse Smac/DIABLO expressed
as COOH-terminal His6-fusion protein in E. coli.
Immunofluorescence analysis
For immunofluorescence analysis, cells were fixed on 8-well tissue culture
slides, washed three times with PBS, permeabilized at 4 C in PBS contain-
ing 0.1% Triton X-100 for 3 min, and incubated with blocking solution
(PBS with 5% horse serum and 0.3% Triton X-100) at room temperature for
30 min. Cyt-c was detected using a monoclonal antinative cyt-c antibody
(clone 6H2.B4, 1:1,000; Becton Dickinson), or the polyclonal anti-Smac/
DIABLO antibody (1:5,000). Antibodies were diluted in PBS containing 1%
horse serum and 0.3% Triton X-100. After incubation at room temperature
for 2 h, cells were washed twice with PBS and incubated with biotin- or
Texas red–conjugated anti–mouse or anti–rabbit IgG antibody (Vector Lab-
oratories) diluted 1:500. The biotin-conjugated secondary antibody was
detected using Oregon green–conjugated streptavidin (Molecular Probes)
diluted 1:1,000 in PBS for 20 min at room temperature. Epifluorescence
microscopy was performed as described below. Chromatin condensation
and fragmentation were visualized by nuclear staining with 1  g/ml of the
DNA-binding fluorescent dye Hoechst 33258 (Sigma-Aldrich).
Time-lapse epifluorescence microscopy and digital imaging
Cells were cultivated on 35-mm glass-bottom dishes (Willco BV) in 150  l
medium for at least overnight to let them attach firmly. Cells were treated
with the indicated concentrations of proapoptotic drugs in Hepes-buffered
medium (10 mM, pH 7.4), covered with embryo-tested mineral oil, and
placed in a heated (37 C) chamber (Minitüb) that was mounted on the mi-
croscope stage. Fluorescence was observed using an inverted microscope
(model TE 300; Eclipse) and a 40  S-Fluor oil objective (Nikon) equipped
with a polychroic mirror and filterwheels in the excitation and emission
light path containing the appropriate filter sets (polychroic mirror with
 50% reflexion from the UV to 443 nm, between 487 and 520 nm, and
between 590 and 640 nm; CFP, excitation 436   10 nm, emission 480  
20 nm; YFP, excitation 500   20 nm, emission 535   30 nm; FRET, exci-
tation 436   10 nm, emission 535   30 nm; AHF Analysentechnik). Emis-
sion and brightfield images were recorded using a CCD camera (Visicam;
Visitron Systems). The imaging setup was controlled by MetaMorph soft-
ware (Universal Imaging Corp.). During control experiments bleaching of
the probe was negligible.
Time-lapse confocal fluorescence microscopy 
and digital imaging
Cyt-c-GFP, Smac/DIABLO-YFP, and TMRM fluorescence was monitored
and quantified confocally using an inverted microscope (model IX70;
Olympus) attached to a confocal laser scanning unit equipped with a 488-
nm argon laser and a 60  oil fluorescence objective (Fluoview; Olympus).
Fluorescence transmitted the first dichroic mirror with  90% transmission
above 505 nm, was divided with a second dichroic mirror at 550 nm, and
detected after transmission of a 510–540-nm bandpass filter (GFP or YFP)
or a 565-nm high pass emission filter (TMRM). There was no TMRM fluo-
rescence detectable in the GFP/YFP channel. The cross talk between the
average pixel intensity of GFP/YFP in the TMRM channel was  10% of the
average pixel intensity in the GFP/YFP channel. The maximum change due
to GFP/YFP fluorescence in the TMRM channel occurred during the re-
lease of the fusion proteins. The resulting change was within the standard
deviation of the average pixel intensity of single cells in the TMRM chan-
nel ( 5%). Fluorescence was detected from a 0.7- m thick confocal sec-
tion (full width half maximum).
The membrane-permeant, cationic probe TMRM distributes across cel-
lular membranes according to the Nernst equation. TMRM has little effects
on the respiratory chain activity at the concentration used in the present
paper (30 nM; Scaduto and Grotyohann, 1999). Saturation of mitochon-
drial TMRM fluorescence was reached at 250 nM extracellular probe con-
centration.
For time-lapse imaging, culture dishes were mounted onto the micro-
scope stage that was equipped with a temperature-controlled inlay (model
HT200; Minitüb). In control experiments constant fluorescence values
were monitored for 24 h in the case of cyt-c-GFP and Smac/DIABLO-YFP
and 18 h in the case of TMRM. Cells were treated with the indicated con-
centrations of proapoptotic drugs in Hepes-buffered medium (10 mM, pH
7.4). To prevent evaporation the medium was covered with embryo-tested
mineral oil. Image data were obtained using Fluoview 2.0 software (Olym-
pus) and Kalman filtered from three scans for each image.
Cyt-c-GFP and Smac/DIABLO-DsRed cotransfected cells were moni-
tored confocally using a microscope (model LSM 510; Carl Zeiss MicroIm-
aging, Inc.) provided with a 63  oil fluorescence objective and a tempera-
ture controlled incubation chamber. The confocal laser scanning unit was
equipped with a 488-nm argon laser (GFP excitation) and a 543-nm he-
lium/neon laser (DsRed excitation; Carl Zeiss MicroImaging, Inc.). Fluores-
cence was detected after transmission of a 505–530-nm bandpass filter
(GFP emission) or a 560-nm high pass emission filter (DsRed emission).
Kinetics of   M depolarization, cyt-c-GFP 
and Smac/DIABLO-YFP release
The quantitative analysis of the fluorescence images was performed using
UTHSCSA ImageTool program (University of Texas Health Science Center)
and MetaMorph software. For analysis of   M kinetics in single cells, the
fluorescent mitochondrial regions were segmented from the cytoplasmic
and nucleus regions. After background subtraction, the average fluores-
cence intensity per pixel was calculated. This value resembles the concen-
tration of TMRM inside mitochondria (Dussmann et al., 2003b).
The release kinetics of cyt-c or Smac/DIABLO are shown as the stan-
dard deviation from the average pixel intensity of individual cells (Gold-
stein et al., 2000). Compartmentalized cyt-c-GFP or Smac/DIABLO-YFP
contributes to a high standard deviation and homogeneously distributed
cyt-c-GFP or Smac/DIABLO-YFP is represented by a low standard devia-
tion. Single cell release kinetics were fitted with the standard exponential
decay function and the corresponding half-life times were calculated. For
direct comparisons and statistical analyses, single cell standard deviation
traces were scaled from 100 (baseline before the release) to 0 (baseline af-
ter completion of the release).
Kinetics of FRET disruption
For comparison of onset of Smac/DIABLO release and DEVDase activa-
tion, cells were cotransfected with plasmids pSmac/DIABLO-YFP and
pmyc-CFP-DEVD-YFP (Tyas et al., 2000; Rehm et al., 2002). Cleavage ki-
netics were detected at the single cell level by FRET analysis. Images were
processed using MetaMorph software. CFP/YFP emission ratios were ob-
tained by dividing the average fluorescence intensity values of single cells
after background subtraction. For direct comparisons, single cell tracesT
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were scaled from 1 to 2. The onset of Smac/DIABLO-YFP release was de-
fined as the time point at which the standard deviation of the Smac/
DIABLO-YFP signal declined irreversibly below the baseline value minus
its standard deviation. The onset of caspase activity was defined as the
time point at which the CFP/YFP ratio irreversibly rose above the baseline
value plus its standard deviation. The time periods between both events
were collected and analyzed statistically.
Statistics
Data are given as means   SD or SEM. For statistical comparison ANOVA
and subsequent Tukey test or t test were used. Data that were not standard
deviated were analyzed by Mann-Whitney U test. P values smaller than
0.05 were considered to be statistically significant.
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